After patients with cancer undergo surgery to remove a tumor and sometimes additional chemotherapy, tools are used to identify patients at highest risk of recurrence. Non-invasive tools to detect microscopic disease are of especially high value. In a new study published in Clinical Cancer Research, a team led by investigators at Massachusetts General Hospital (MGH) has evaluated the first tumor-uninformed test that detects cancer DNA circulating in the blood of patients following treatment.
- Read more about New test detects residual cancer DNA in the blood without relying on tumor data
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2021/new-test-detects-residual-cancer-dna-in-the-blood-without-relying-on-tumor-data
No comments:
Post a Comment